InterVene is a medical device company that treats severe venous disease in the legs.
InterVene has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
InterVene's investors include Correlation Ventures, Boston Scientific, RiverVest, Treo Ventures, LaunchCapital.
InterVene is headquartered in South San Francisco, United States.
InterVene is a medical device company that treats severe venous disease in the legs.
InterVene is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InterVene — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/intervene. Accessed July 20, 2026.
VCBacked. (2024). InterVene — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/intervene
{{cite web |title=InterVene — Funding & Investors |url=https://www.vcbacked.co/company/intervene |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated